CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net income	$ 2,151	$ 1,547
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	4,253	2,402
Amortization of deferred financing costs charged to interest expense	642	276
Stock-based compensation expense	620	552
Deferred taxes, net	(6)	(13)
Changes in operating assets and liabilities
Accounts receivable	3,542	780
Other assets	510	994
Accounts payable and accrued liabilities	(7,397)	1,075
Accrued payroll	1,909	347
Other liabilities	(1,153)	13
Net cash provided by operating activities	5,071	7,973
Investing activities
Business acquisition, net of cash acquired	0	(179,958)
Purchase of equipment and improvements	(174)	(384)
Net cash used in investing activities	(174)	(180,342)
Financing activities
Proceeds from revolving line of credit	69,831	0
Repayment of revolving line of credit	(64,026)	0
Proceeds from debt obligations	0	200,703
Repayments of debt obligations	(10,378)	(19,327)
Payments of deferred financing costs	0	(7,221)
Proceeds from issuance of common stock upon exercise of options and warrants	261	0
Payment of tax obligations resulting from net exercise of stock options	(669)	(650)
Net cash provided by (used in) financing activities	(4,981)	173,505
Net change in cash	(84)	1,136
Cash - beginning of period	215	228
Cash - end of period	131	1,364
Supplemental disclosure of cash flow information
Cash paid during the period for interest	3,972	339
Cash paid during the period for income taxes	0	5
Common stock surrendered for the exercise of stock options	$ 244	$ 238